Although no differences of primary tumour growth were observed (Fig. 5f), a higher number of IL-33-tumour-bearing mice developed luciferase+ pulmonary metastasis as compared with the vector control group (Fig. 5g). This evidence concerns the gene IL33 and neoplasm.